3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Venous Thromboembolism
5
Neoplasms
2
Thrombosis
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Glioma
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
Oxaliplatin
166
Capecitabine
112
Fluorouracil
95
Docetaxel
85
Cisplatin
84
S 1 (combination)
83
Leucovorin
64
Paclitaxel
58
Irinotecan
56
pembrolizumab
36
sintilimab
34
Trastuzumab
34
apatinib
30
Bevacizumab
21
Surgical Procedures, Operative
19
Radiotherapy
19
titanium silicide
17
camrelizumab
17
Nivolumab
17
Ramucirumab
16
Drug Therapy
15
Hyperthermic Intraperitoneal Chemotherapy
14
Folfox protocol
14
Epirubicin
14
tislelizumab
13
Neoadjuvant Therapy
12
Cetuximab
12
XELOX
10
Tegafur
10
Carboplatin
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Stomach Neoplasms
×
apixaban
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled